PB Anti-Human IgG Fc antibody
英诺赛图(InnoCyto)的 PB Anti-Human IgG Fc antibody(克隆 1007AM1) 为鼠源 IgG1 单克隆抗体,靶向 Human IgG Fcγ,PB 标记(405 nm 紫外激光激发),适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥1,290 起,仅供科研使用(RUO)。
01产品图片

02产品简介
英诺赛图(InnoCyto)的 PB Anti-Human IgG Fc antibody(克隆 1007AM1) 为鼠源 IgG1 单克隆抗体,靶向 Human IgG Fcγ,PB 标记(405 nm 紫外激光激发),适用于流式细胞术。提供 25 μg、100 μg 规格,目录价 ¥1,290 起,仅供科研使用(RUO)。
03产品介绍
规格与货号
306605 | 25 μg | ¥1,290
306606 | 100 μg | ¥2,850
Product Details
Regulatory Status|RUO
Protein Concentration|0.2 mg/mL
Storage & Handling|The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Recommended Usage|For flow cytometric staining, it is recommended to use less than 0.2 μg of this reagent per 0.5-1.0 million cells in a 100 µL volume. Optimal reagent performance should be determined by titration for each specific application
See All Formats|Clone 1007AM1
Background Information
The human IgG Fc region is the constant (fragment crystallizable) portion of immunoglobulin G (IgG) antibodies that mediates communication between antibodies and the immune system. Although the Fc region does not bind antigen directly, it recruits immune effector mechanisms after the antigen-binding Fab regions recognize their targets. Through interactions with Fc gamma (Fcγ) receptors expressed on macrophages, neutrophils, dendritic cells, natural killer (NK) cells, and other leukocytes, as well as complement component C1q, the IgG Fc region triggers antibody-dependent cellular cytotoxicity (ADCC), antibody-dependent cellular phagocytosis (ADCP), complement-dependent cytotoxicity (CDC), and modulation of inflammatory responses. The Fc region also binds the neonatal Fc receptor (FcRn), which protects IgG from lysosomal degradation and extends its serum half-life to approximately three weeks.
Structurally, the IgG Fc region consists of the paired heavy-chain constant domains CH2 and CH3 connected by a flexible hinge region. The Fc forms a homodimer stabilized by disulfide bonds and contains a conserved N-linked glycosylation site at Asn297 within each CH2 domain. Fc glycosylation is essential for maintaining the proper conformation required for Fcγ receptor and C1q binding, and changes in glycan composition can markedly alter antibody effector function. Major ligands include activating Fcγ receptors (FcγRI, FcγRIIA, FcγRIIIA), the inhibitory receptor FcγRIIB, FcRn, and C1q.
Altered Fc-mediated signaling contributes to numerous diseases. Excessive Fcγ receptor activation by immune complexes promotes autoimmune disorders such as systemic lupus erythematosus, rheumatoid arthritis, and immune thrombocytopenia, while impaired Fc function can reduce pathogen clearance and antitumor immunity. Differences in Fc glycosylation have also been associated with chronic inflammatory diseases, infections, and cancer.
The IgG Fc region is a major focus of therapeutic antibody engineering. Fc modifications can enhance or reduce Fcγ receptor binding, prolong serum half-life through improved FcRn interactions, or eliminate unwanted effector functions. Engineered Fc domains are widely incorporated into monoclonal antibodies, bispecific antibodies, Fc-fusion proteins, and antibody-drug conjugates to optimize efficacy, safety, and pharmacokinetics, making the human IgG Fc region a cornerstone of modern immunotherapy.
Data Sheets
Human peripheral blood monocytes were stained with Purified Anti-Human CD14 clone Hm2F9 (color-filled histogram) or an isotype control (gray histogram), followed by PB Anti-Human IgG Fc clone 1007AM1.
04完整参数表
参数由厂商资料整理,采购前请以最终报价单与技术协议为准。
05荣誉与资质
该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。
- 营业执照未上传
- 品牌授权未上传
- 产品检测报告未上传
- 会员身份
- 收费会员
- 经营身份
- 原厂
- 成立年份
- 2020 年
- 所在地
- 上海
- 收录条目
- 1865 个
- 平台核验
- 平台代管
06品牌与供应商
InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。
品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。
07同类条目
同一子类内的条目才具备可比性。跨子类比较参数通常没有意义。
08同品牌其他条目
上海英诺赛图 在本目录共 1865 个条目,除本条外还有:
科研在线(TeleVM). PB Anti-Human IgG Fc antibody(306605)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/pb-anti-human-igg-fc-antibody.html.
TeleVM. (2026, November 12). PB Anti-Human IgG Fc antibody(306605). 产品目录. https://www.suprotek.cn/products/item/pb-anti-human-igg-fc-antibody.html
@misc{biocsp_item_pb_anti_human_igg_fc_antibody,
title = {PB Anti-Human IgG Fc antibody(306605)},
author = {{科研在线}},
year = {2026},
howpublished = {产品目录},
note = {更新于 2026-11-12,产品目录},
url = {https://www.suprotek.cn/products/item/pb-anti-human-igg-fc-antibody.html}
}
GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。
许可:CC BY-NC 4.0 · 转载注明来源